Agonist and Inverse Agonist Efficacy at Human Recombinant Serotonin 5-HT1A Receptors as a Function of Receptor:G-protein Stoichiometry
- 17 August 1998
- journal article
- Published by Elsevier
- Vol. 36 (4-5) , 451-459
- https://doi.org/10.1016/s0028-3908(97)00022-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Inhibition of the constitutive activity of human 5‐HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635British Journal of Pharmacology, 1997
- Differentiation of NG108‐15 Neuroblastoma Cells by Serum Starvation or Dimethyl Sulfoxide Results in Marked Differences in Angiotensin II Receptor Subtype ExpressionJournal of Neurochemistry, 1996
- Development of 5-HT1A receptor antagonistsBehavioural Brain Research, 1995
- Constitutive activation of muscarinic receptors by the G‐protein GqFEBS Letters, 1995
- Combined in situ hybridisation, northern blot analysis, and receptor binding studies in clones expressing different levels of the human 5-HT1A receptorJournal of Receptors and Signal Transduction, 1995
- Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein .alpha.-subunits and lack of coupling to Gs.alpha.Biochemistry, 1993
- Partial agonists, full agonists, antagonists: dilemmas of definitionTrends in Pharmacological Sciences, 1993
- Reverse intrinsic activity of antagonists on G protein-coupled receptorsTrends in Pharmacological Sciences, 1992
- NEUROCHEMICAL PROFILE OF ELTOPRAZINEDrug Metabolism and Drug Interactions, 1990
- The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptorNature, 1988